3M announces its submission for 510(k) clearance with the U.S. Food and Drug Administration (FDA) for its Attest™ Super Rapid System for Steam Sterilization, which will provide biological indicator (BI) results in 24 minutes. The clearance of a faster readout time for steam will continue to enhance patient safety while increasing workflow advantages for sterilization professionals.
“The focus of our sterilization science at 3M is on increasing patient safety through every means possible,” began Srini Raman, 3M Business Director of Device Reprocessing. “One of the best ways we can do that is to make it easy for sterilization departments to know that every load of medical instruments has met standards for sterilization before they’re released for surgery. We introduced a 24-minute readout for VH202 in July and it was met with great market excitement. Our next goal was to take this same science and apply it to steam sterilization monitoring, which 3M has been a progressive leader in for over 40 years.”
The addition of the 3M™ Attest™ 490 Auto-reader to 3M’s sterilization portfolio, pending 510(k) clearance, will mean customers can count on 3M for a simplified, standardized approach to BI processing for both Steam and VH2O2 results in just 24 minutes.
The new system will utilize existing hardware and will continue to use the same BI technology that customers use today.
Source: 3M
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.